Low dose Rituximab for pre-emptive treatment of Epstein Barr virus reactivation after allogenic hematopoietic stem cell transplantation
Delapierre, B., Reman, O., Dina, J., Breuil, C., Bellal, M., Johnson-Ansah, H., Gac, A.C., Damaj, G., Chantepie, S.
Published in Current research in translational medicine (01.11.2019)
Published in Current research in translational medicine (01.11.2019)
Get full text
Journal Article
First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia
REA, D, ETIENNE, G, ROUSSELOT, P, CAYUELA, J.-M, GUILHOT, F, MAHON, F.-X, NICOLINI, F, CONY-MAKHOUL, P, JOHNSON-ANSAH, H, LEGROS, L, HUGUET, F, TULLIEZ, M, GARDEMBAS, M, BOUABDALLAH, K
Published in Leukemia (01.10.2012)
Published in Leukemia (01.10.2012)
Get full text
Journal Article
Predictive factors for a single successful cytapheresis session during the first mobilisation
Gac, A.C, Parienti, J.J, Chantepie, S, Cheze, S, Johnson-Ansah, H, Benabed, K, Macro, M, Lefevre, V, Batho, A, Fruchart, C, Reman, O
Published in Leukemia research (01.09.2014)
Published in Leukemia research (01.09.2014)
Get full text
Journal Article